← brief for 2026-08-13 · Slowing decline
Ozempic
Key takeaways
This trial showed semaglutide reduces risk of kidney failure and cardiovascular death. It was a large trial with 3,200 patients over 3 years.
Who did this work
A-S Medication Solutions
Source
Paper · openFDA, renal drug labels · 2026-07-30
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42bdd912-2393-44c4-b7e0-47672ca28991